These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 36513280)

  • 1. CLCN7, a gene shared by autosomal recessive and autosomal dominant osteopetrosis.
    Stauber T; Wartosch L; Vishnolia S; Schulz A; Kornak U
    Bone; 2023 Mar; 168():116639. PubMed ID: 36513280
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lysosomal pathology and osteopetrosis upon loss of H+-driven lysosomal Cl- accumulation.
    Weinert S; Jabs S; Supanchart C; Schweizer M; Gimber N; Richter M; Rademann J; Stauber T; Kornak U; Jentsch TJ
    Science; 2010 Jun; 328(5984):1401-3. PubMed ID: 20430974
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pathobiologic Mechanisms of Neurodegeneration in Osteopetrosis Derived From Structural and Functional Analysis of 14 ClC-7 Mutants.
    Di Zanni E; Palagano E; Lagostena L; Strina D; Rehman A; Abinun M; De Somer L; Martire B; Brown J; Kariminejad A; Balasubramaniam S; Baynam G; Gurrieri F; Pisanti MA; De Maggio I; Abboud MR; Chiesa R; Burren CP; Villa A; Sobacchi C; Picollo A
    J Bone Miner Res; 2021 Mar; 36(3):531-545. PubMed ID: 33125761
    [TBL] [Abstract][Full Text] [Related]  

  • 4. ClC-7 expression levels critically regulate bone turnover, but not gastric acid secretion.
    Supanchart C; Wartosch L; Schlack C; Kühnisch J; Felsenberg D; Fuhrmann JC; de Vernejoul MC; Jentsch TJ; Kornak U
    Bone; 2014 Jan; 58():92-102. PubMed ID: 24103576
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clcn7
    Caetano-Lopes J; Lessard SG; Hann S; Espinoza K; Kang KS; Lim KE; Horan DJ; Noonan HR; Hu D; Baron R; Robling AG; Warman ML
    Bone; 2017 Dec; 105():253-261. PubMed ID: 28942122
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Novel mutations of CLCN7 cause autosomal dominant osteopetrosis type II (ADO-II) and intermediate autosomal recessive osteopetrosis (IARO) in Chinese patients.
    Pang Q; Chi Y; Zhao Z; Xing X; Li M; Wang O; Jiang Y; Liao R; Sun Y; Dong J; Xia W
    Osteoporos Int; 2016 Mar; 27(3):1047-1055. PubMed ID: 26395888
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chloride channel 7 (ClCN7) gene mutations and autosomal dominant osteopetrosis, type II.
    Waguespack SG; Koller DL; White KE; Fishburn T; Carn G; Buckwalter KA; Johnson M; Kocisko M; Evans WE; Foroud T; Econs MJ
    J Bone Miner Res; 2003 Aug; 18(8):1513-8. PubMed ID: 12929941
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impaired Autophagic Clearance with a Gain-of-Function Variant of the Lysosomal Cl
    Bose S; de Heus C; Kennedy ME; Wang F; Jentsch TJ; Klumperman J; Stauber T
    Biomolecules; 2023 Dec; 13(12):. PubMed ID: 38136669
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gain-of-function variants in CLCN7 cause hypopigmentation and lysosomal storage disease.
    Polovitskaya MM; Rana T; Ullrich K; Murko S; Bierhals T; Vogt G; Stauber T; Kubisch C; Santer R; Jentsch TJ
    J Biol Chem; 2024 Jul; 300(7):107437. PubMed ID: 38838776
    [TBL] [Abstract][Full Text] [Related]  

  • 10. ClC-7 Regulates the Pattern and Early Development of Craniofacial Bone and Tooth.
    Zhang Y; Ji D; Li L; Yang S; Zhang H; Duan X
    Theranostics; 2019; 9(5):1387-1400. PubMed ID: 30867839
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A missense mutation accelerating the gating of the lysosomal Cl-/H+-exchanger ClC-7/Ostm1 causes osteopetrosis with gingival hamartomas in cattle.
    Sartelet A; Stauber T; Coppieters W; Ludwig CF; Fasquelle C; Druet T; Zhang Z; Ahariz N; Cambisano N; Jentsch TJ; Charlier C
    Dis Model Mech; 2014 Jan; 7(1):119-28. PubMed ID: 24159188
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Loss of the ClC-7 chloride channel leads to osteopetrosis in mice and man.
    Kornak U; Kasper D; Bösl MR; Kaiser E; Schweizer M; Schulz A; Friedrich W; Delling G; Jentsch TJ
    Cell; 2001 Jan; 104(2):205-15. PubMed ID: 11207362
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficient generation of osteoclasts from human induced pluripotent stem cells and functional investigations of lethal CLCN7-related osteopetrosis.
    Rössler U; Hennig AF; Stelzer N; Bose S; Kopp J; Søe K; Cyganek L; Zifarelli G; Ali S; von der Hagen M; Strässler ET; Hahn G; Pusch M; Stauber T; Izsvák Z; Gossen M; Stachelscheid H; Kornak U
    J Bone Miner Res; 2021 Aug; 36(8):1621-1635. PubMed ID: 33905594
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Novel CLCN7 mutations cause autosomal dominant osteopetrosis type II and intermediate autosomal recessive osteopetrosis.
    Li L; Lv SS; Wang C; Yue H; Zhang ZL
    Mol Med Rep; 2019 Jun; 19(6):5030-5038. PubMed ID: 30942407
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Albers-Schönberg disease (autosomal dominant osteopetrosis, type II) results from mutations in the ClCN7 chloride channel gene.
    Cleiren E; Bénichou O; Van Hul E; Gram J; Bollerslev J; Singer FR; Beaverson K; Aledo A; Whyte MP; Yoneyama T; deVernejoul MC; Van Hul W
    Hum Mol Genet; 2001 Dec; 10(25):2861-7. PubMed ID: 11741829
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Role of the Lysosomal Cl
    Zifarelli G
    Cells; 2022 Jan; 11(3):. PubMed ID: 35159175
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Autosomal dominant osteopetrosis associated with renal tubular acidosis is due to a CLCN7 mutation.
    Piret SE; Gorvin CM; Trinh A; Taylor J; Lise S; Taylor JC; Ebeling PR; Thakker RV
    Am J Med Genet A; 2016 Nov; 170(11):2988-2992. PubMed ID: 27540713
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chloride channel ClCN7 mutations are responsible for severe recessive, dominant, and intermediate osteopetrosis.
    Frattini A; Pangrazio A; Susani L; Sobacchi C; Mirolo M; Abinun M; Andolina M; Flanagan A; Horwitz EM; Mihci E; Notarangelo LD; Ramenghi U; Teti A; Van Hove J; Vujic D; Young T; Albertini A; Orchard PJ; Vezzoni P; Villa A
    J Bone Miner Res; 2003 Oct; 18(10):1740-7. PubMed ID: 14584882
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Disease status in autosomal dominant osteopetrosis type 2 is determined by osteoclastic properties.
    Chu K; Snyder R; Econs MJ
    J Bone Miner Res; 2006 Jul; 21(7):1089-97. PubMed ID: 16813529
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.